Genomics to select treatment for patients with metastatic breast cancer
Google News,
Abstract Cancer progression is driven in part by genomic alterations1. The genomic characterization of cancers has shown…
Abstract Cancer progression is driven in part by genomic alterations1. The genomic characterization of cancers has shown…
ESMO, the leading professional organisation for medical oncology, is pleased to announce the publication of the ESMO Precision…
SOURCE European Society for Medical Oncology (ESMO) LUGANO, Switzerland ESMO has published today the ESMO Precision Medicine…
SOURCE European Society for Medical Oncology (ESMO) LUGANO, Switzerland ESMO has published today the ESMO Precision Medicine…